fluoromethyl 2,2-difluoro-1-(trifluoromethyl)vinyl ether has been researched along with Liver Diseases in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bowland, T; Eger, EI; Gong, D; Ionescu, P; Koblin, DD; Laster, MJ; Weiskopf, RB | 1 |
1 other study(ies) available for fluoromethyl 2,2-difluoro-1-(trifluoromethyl)vinyl ether and Liver Diseases
| Article | Year |
|---|---|
Dose-related biochemical markers of renal injury after sevoflurane versus desflurane anesthesia in volunteers.
Topics: Adult; Anesthesia, General; Anesthetics, Inhalation; Biomarkers; Chemical and Drug Induced Liver Injury; Desflurane; Dose-Response Relationship, Drug; Ethers; Fluorides; Humans; Hydrocarbons, Fluorinated; Isoflurane; Kidney Diseases; Kidney Glomerulus; Liver Diseases; Male; Methyl Ethers; Sevoflurane; Temperature; Tidal Volume | 1997 |